Top Stories

Pfizer expects elderly, those with health conditions to be first


A healthcare worker gives the Pfizer/BioNTech vaccine to Norman G. Einspruch, 88, a cardiology patient, as part of COVID-19 vaccination plan for the seniors at the Jackson Memorial Hospital in Miami, Florida, United States on December 30, 2020.

Marco Bello | Anadolu Agency | Getty Images

High-risk groups such as the elderly and people with underlying medical conditions are expected to be the first in line to get booster shots of the PfizerBioNTech Covid-19 vaccine, the company’s chief scientific officer told investors Tuesday.

The two-dose vaccine has been shown to be about 95% effective against Covid two weeks after the second dose, though researchers who helped develop the shot now say…


Rates may have to rise somewhat to keep economy from overheating

Previous article

Cathie Wood’s Ark Innovation ETF drops nearly 5% amid tech sell-off, is now off 30% from high

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories